The DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Early intervention and prevention of lung disease in cystic fibrosis: a European consensus
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Manual of Clinical Microbiology
Blair, J. E., Lennette, E. H., & Truant, J. P. (1970) · Postgraduate Medical Journal · doi:10.1136/pgmj.46.542.733-c · Cited by 2,642
Extracellular DNA Required for Bacterial Biofilm Formation
Whitchurch, C. B., Tolker-Nielsen, T., Ragas, P. C., & Mattick, J. S. (2002) · Science · doi:10.1126/science.295.5559.1487 · Cited by 2,203
Nasal Carriage as a Source of Staphylococcus aureus Bacteremia
von Eiff, C., Becker, K., Machka, K., Stammer, H., & Peters, G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440102 · Cited by 1,984
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
Govan, J. R. W., & Deretic, V. P. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.3.539-574.1996 · Cited by 1,812
Manual of Clinical Microbiology, 7th ed.
Balows, A. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00102-9 · Cited by 1,613
Fuchs, H. J., Borowitz, D. S., Christiansen, D. H., Morris, E. M., Nash, M. L., Ramsey, B. W., Rosenstein, B. J., Smith, A. L., & Wohl, M. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409083311003 · Cited by 1,539
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Pepe, M. S., Quan, J. M., Otto, K. L., Montgomery, A. B., Williams-Warren, J., Vasiljev-K, M., Borowitz, D., Bowman, C. M., Marshall, B. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400104 · Cited by 1,300
Warren, J. W., Abrutyn, E., Hebel, J. R., Johnson, J. R., Schaeffer, A. J., & Stamm, W. E. (1999) · Clinical Infectious Diseases · doi:10.1086/520427 · Cited by 1,188
CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE: A CLINICAL AND PATHOLOGIC STUDY
ANDERSEN, D. H. (1938) · American Journal of Diseases of Children · doi:10.1001/archpedi.1938.01980140114013 · Cited by 1,146
Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U. E., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiß, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13870 · Cited by 1,099
Self-citationBobadilla, J. L., Macek, M., Fine, J. P., & Farrell, P. M. (2002) · Human Mutation · doi:10.1002/humu.10041 · Cited by 1,032
Walters, M. C., Roe, F., Bugnicourt, A., Franklin, M. J., & Stewart, P. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.317-323.2003 · Cited by 988
Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiss, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213870 · Cited by 932
Self-citationNickel, J. C., Ruseska, I., Wright, J. B., & Costerton, J. W. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.4.619 · Cited by 889
Ratjen, F., & Döring, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12567-6 · Cited by 885
Self-citationMicrobiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
Denton, M., & Kerr, K. G. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.1.57 · Cited by 852
Farrell, P. M., Kosorok, M. R., Rock, M. J., Laxova, A., Zeng, L., Lai, H.-C., Hoffman, G., Laessig, R. H., Splaingard, M. L., & the Wisconsin Cystic Fibrosis Neonatal Screening Study Group (2001) · Pediatrics · doi:10.1542/peds.107.1.1 · Cited by 837
Intranasal Mupirocin to Prevent Postoperative Staphylococcus aureus Infections
Perl, T. M., Cullen, J. J., Wenzel, R. P., Zimmerman, M. B., Pfaller, M. A., Sheppard, D., Twombley, J., French, P. P., & Herwaldt, L. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa003069 · Cited by 799
H1-Receptor Antagonists: Comparative Tolerability and Safety
Estelle, F., & Simons, R. (1994) · Drug Safety · doi:10.2165/00002018-199410050-00002 · Cited by 751
Predictive 5-year survivorship model of cystic fibrosis
Liou, T. G., Adler, F. R., FitzSimmons, S. C., Cahill, B. C., Hibbs, J. R., & Marshall, B. C. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.4.345 · Cited by 749
Effect of High-Dose Ibuprofen in Patients with Cystic Fibrosis
Konstan, M. W., Byard, P. J., Hoppel, C. L., & Davis, P. B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503303321303 · Cited by 726
Inflammatory cytokines in cystic fibrosis lungs.
Bonfield, T. L., Panuska, J. R., Konstan, M. W., Hilliard, K. A., Hilliard, J. B., Ghnaim, H., & Berger, M. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.6.8520783 · Cited by 711
Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.
Shak, S., Capon, D. J., Hellmiss, R., Marsters, S. A., & Baker, C. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9188 · Cited by 707
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus
Döring, G., Conway, S. P., Heijerman, H. G. M., Hodson, M. E., Høiby, N., Smyth, A., Touw, D. J., & the Consensus Committee, F. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.16d30.x · Cited by 620
Self-citationTenover, F. C., Arbeit, R. D., Goering, R. V., & Molecular Typing Working Group of the Society for Healthcare Epidemiology of America (1997) · Infection Control & Hospital Epidemiology · doi:10.1086/647644 · Cited by 588
Longitudinal Assessment of Pseudomonas aeruginosa in Young Children with Cystic Fibrosis
Burns, J. L., Gibson, R. L., McNamara, S., Yim, D., Emerson, J., Rosenfeld, M., Hiatt, P., McCoy, K., Castile, R., Smith, A. L., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/318075 · Cited by 555
Equi, A., Balfour-Lynn, I., Bush, A., & Rosenthal, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11081-6 · Cited by 543
Konstan, M. W., Hilliard, K. A., Norvell, T. M., & Berger, M. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.2.8049828 · Cited by 520
Wolter, J. (2002) · Thorax · doi:10.1136/thorax.57.3.212 · Cited by 518
Mathee, K., Ciofu, O., Sternberg, C., Lindum, P. W., Campbell, J. I. A., Jensen, P., Johnsen, A. H., Givskov, M., Ohman, D. E., Søren, M., et al. (1999) · Microbiology · doi:10.1099/13500872-145-6-1349 · Cited by 484
Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment
Valerius, N. H., Koch, C., & Høiby, N. (1991) · The Lancet · doi:10.1016/0140-6736(91)91446-2 · Cited by 475
Frederiksen, B., Koch, C., & Høiby, N. (1997) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199705)23:5<330::aid-ppul4>3.0.co;2-o · Cited by 473
Lower Airway Inflammation in Infants and Young Children with Cystic Fibrosis
ARMSTRONG, D. S., GRIMWOOD, K., CARLIN, J. B., CARZINO, R., GUTIÈRREZ, J. P., HULL, J., OLINSKY, A., PHELAN, E. M., ROBERTSON, C. F., & PHELAN, P. D. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.4.96-11058 · Cited by 467
Hancock, R. E., Mutharia, L. M., Chan, L., Darveau, R. P., Speert, D. P., & Pier, G. B. (1983) · Infection and Immunity · doi:10.1128/iai.42.1.170-177.1983 · Cited by 461
Clarke, M. E., Knight, S., & Prozesky, D. R. (2003) · Cited by 442
Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis
Nixon, G. M., Armstrong, D. S., Carzino, R., Carlin, J. B., Olinsky, A., Robertson, C. F., & Grimwood, K. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.112897 · Cited by 432
Taxonomy and Identification of the Burkholderia cepacia Complex
Coenye, T., Vandamme, P., Govan, J. R. W., & LiPuma, J. J. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.10.3427-3436.2001 · Cited by 432
NOSOCOMIAL OUTBREAKS/PSEUDO OUTBREAKS CAUSED BY NONTUBERCULOUS MYCOBACTERIA
Wallace, R. J., Brown, B. A., & Griffith, D. E. (1998) · Annual Review of Microbiology · doi:10.1146/annurev.micro.52.1.453 · Cited by 430
Microbiology of Sputum from Patients at Cystic Fibrosis Centers in the United States
Burns, J. L., Emerson, J., Stapp, J. R., Yim, D. L., Krzewinski, J., Louden, L., Ramsey, B. W., & Clausen, C. R. (1998) · Clinical Infectious Diseases · doi:10.1086/514631 · Cited by 421
Parke, J. L., & Gurian-Sherman, D. (2001) · Annual Review of Phytopathology · doi:10.1146/annurev.phyto.39.1.225 · Cited by 402
Kosorok, M. R., Zeng, L., West, S. E. H., Rock, M. J., Splaingard, M. L., Laxova, A., Green, C. G., Collins, J., & Farrell, P. M. (2001) · Pediatric Pulmonology · doi:10.1002/ppul.2009.abs · Cited by 400
Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis*
Rosenfeld, M., Gibson, R. L., McNamara, S., Emerson, J., Burns, J. L., Castile, R., Hiatt, P., McCoy, K., Wilson, C. B., Inglis, A., et al. (2001) · Pediatric Pulmonology · doi:10.1002/ppul.1144 · Cited by 395
Nutritional Benefits of Neonatal Screening for Cystic Fibrosis
Farrell, P. M., Kosorok, M. R., Laxova, A., Shen, G., Koscik, R. E., Bruns, W. T., Splaingard, M., & Mischler, E. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371403 · Cited by 388
Handling uncertainty when performing economic evaluation of healthcare interventions.
Briggs, & Gray (1999) · Health Technology Assessment · doi:10.3310/hta3020 · Cited by 387
Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
Birrer, P., McElvaney, N. G., Rüdeberg, A., Sommer, C. W., Liechti-Gallati, S., Kraemer, R., Hubbard, R., & Crystal, R. G. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.1.7912987 · Cited by 382
Broadly Protective Vaccine for Staphylococcus aureus Based on an in Vivo-Expressed Antigen
McKenney, D., Pouliot, K. L., Wang, Y., Murthy, V., Ulrich, M., Döring, G., Lee, J. C., Goldmann, D. A., & Pier, G. B. (1999) · Science · doi:10.1126/science.284.5419.1523 · Cited by 371
Kahl, B., Herrmann, M., Everding, A. S., Koch, H. G., Becker, K., Harms, E., Proctor, R. A., & Peters, G. (1998) · Journal of Infectious Diseases · doi:10.1086/515238 · Cited by 357
Exhaled breath condensate: An evolving tool for noninvasive evaluation of lung disease
Hunt, J. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.124966 · Cited by 345
Cramton, S. E., Ulrich, M., Götz, F., & Döring, G. (2001) · Infection and Immunity · doi:10.1128/iai.69.6.4079-4085.2001 · Cited by 345
Aerosol α1 -antitrypsin treatment for cystic fibrosis
McElvaney, N. G., Hubbard, R. C., Birrer, P., Crystal, R. G., Chernick, M. S., Frank, M. M., & Caplan, D. B. (1991) · The Lancet · doi:10.1016/0140-6736(91)91167-s · Cited by 325
Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis
Gibson, R. L., Emerson, J., McNamara, S., Burns, J. L., Rosenfeld, M., Yunker, A., Hamblett, N., Accurso, F., Dovey, M., Hiatt, P., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-855oc · Cited by 318
Saiman, L. (2003) · American Journal of Infection Control · doi:10.1067/mic.2003.78 · Cited by 307
ALTERNATE-DAY PREDNISONE REDUCES MORBIDITY AND IMPROVES PULMONARY FUNCTION IN CYSTIC FIBROSIS
Auerbach, H., Kirkpatrick, J., Williams, M., & Colten, H. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92929-0 · Cited by 302
Quan, J. M., Tiddens, H. A. W. M., Sy, J. P., McKenzie, S. G., Montgomery, M. D., Robinson, P. J., Wohl, M. E. B., & Konstan, M. W. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.118570 · Cited by 301
McElvaney, N. G., Nakamura, H., Birrer, P., Hébert, C. A., Wong, W. L., Alphonso, M., Baker, J. B., Catalano, M. A., & Crystal, R. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115994 · Cited by 299
EXPENDITURE ON N.H.S. PRACTICE PREMISES. THE MINISTER'S LETTER.
Barber, A. C. (1964) · PubMed · Cited by 293
Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection
Demko, C. A., Byard, P. J., & Davis, P. B. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00230-n · Cited by 289
Co-Chairmen of the Task Force:, Boe, J., Dennis, J. H., O'Driscoll, B. R., Members of Task Force:, Bauer, T. T., Carone, M., Dautzenberg, B., Diot, P., Heslop, K., et al. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00220001 · Cited by 280
Allergic bronchopulmonary aspergillosis in cystic fibrosis
Laufer, P., Fink, J. N., Bruns, W. T., Unger, G. F., Kalbfleisch, J. H., Greenberger, P. A., & Patterson, R. (1984) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(84)90482-2 · Cited by 278
Oliver, A., Baquero, F., & Blázquez, J. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02855.x · Cited by 267
Robinson, M., Hemming, A. L., Regnis, J. A., Wong, A. G., Bailey, D. L., Bautovich, G. J., King, M., & Bye, P. T. (1997) · Thorax · doi:10.1136/thx.52.10.900 · Cited by 265
Regelmann, W. E., Elliott, G. R., Warwick, W. J., & Clawson, C. C. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.4_pt_1.914 · Cited by 262
An overview of the pathogenesis of cystic fibrosis lung disease
Boucher, R. C. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00144-8 · Cited by 254
LiPUMA, J. J., SPILKER, T., GILL, L. H., CAMPBELL, P. W., LIU, L., & MAHENTHIRALINGAM, E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.1.2011153 · Cited by 252
Incidence, population, and survival of cystic fibrosis in the UK, 1968-95
Dodge, J. A., Morison, S., Lewis, P. A., Coles, E. C., Geddes, D., Russell, G., Littlewood, J. M., & Scott, M. T. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.6.493 · Cited by 252
Nasal and Bronchoalveolar Lavage Fluid Cytokines in Early Cystic Fibrosis
Noah, T. L., Black, H. R., Cheng, P.-W., Wood, R. E., & Leigh, M. W. (1997) · Journal of Infectious Diseases · doi:10.1093/infdis/175.3.638 · Cited by 251
Mahadeva, R., Dodge, J. A., Webb, K., Westerbeek, R. C., Carroll, N. R., Dodd, M. E., Bilton, D., & Lomas, D. A. (1998) · BMJ · doi:10.1136/bmj.316.7147.1771 · Cited by 248
Cystic Fibrosis Sputum: A Barrier to the Transport of Nanospheres
SANDERS, N. N., DE SMEDT, S. C., VAN ROMPAEY, E., SIMOENS, P., DE BAETS, F., & DEMEESTER, J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.9909009 · Cited by 248
Quantitative Deposition of Aerosolized Gentamicin in Cystic Fibrosis
Ilowite, J. S., Gorvoy, J. D., & Smaldone, G. C. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.6.1445 · Cited by 247
Frederiksen, B., Lanng, S., Koch, C., & Hølby, N. (1996) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199603)21:3<153::aid-ppul1>3.0.co;2-r · Cited by 247
Microbial Survival in the Environment
Mitscherlich, E., & Marth, E. H. (1984) · Springer eBooks · doi:10.1007/978-3-642-69974-0 · Cited by 246
Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study
Mastella, G., Rainisio, M., Harms, H. K., Hodson, M. E., Koch, C., Navarro, J., Strandvik, B., McKenzie, S. G., & the investigators of the Epidemiologic Registry of Cystic Fibrosis, O. B. O. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.016003464.x · Cited by 244
Burkholderia cenocepacia sp. nov.—a new twist to an old story
Vandamme, P., Holmes, B., Coenye, T., Goris, J., Mahenthiralingam, E., LiPuma, J. J., & Govan, J. R. W. (2003) · Research in Microbiology · doi:10.1016/s0923-2508(03)00026-3 · Cited by 238
Abman, S. H., Ogle, J. W., Butler-Simon, N., Rumack, C. M., & Accurso, F. J. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80008-8 · Cited by 237
Multiparametric analysis of waterline contamination in dental units
Barbeau, J., Tanguay, R., Faucher, E., Avezard, C., Trudel, L., Côté, L., & Prévost, A. P. (1996) · Applied and Environmental Microbiology · doi:10.1128/aem.62.11.3954-3959.1996 · Cited by 237
Saiman, L., Siegel, J., & Cystic Fibrosis Foundation Consensus Conference on Infection Control Participants (2003) · Infection Control & Hospital Epidemiology · doi:10.1086/503485 · Cited by 235
Wang, E. E. L., Prober, C. G., Manson, B., Corey, M., & Levison, H. (1984) · New England Journal of Medicine · doi:10.1056/nejm198412273112602 · Cited by 235
Inflammation, Infection, and Pulmonary Function in Infants and Young Children with Cystic Fibrosis
DAKIN, C. J., NUMA, A. H., WANG, H., MORTON, J. R., VERTZYAS, C. C., & HENRY, R. L. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.7.2010139 · Cited by 233
Purpose of Quality Standards for Infectious Diseases
Gross, P. A., Barrett, T. L., Dellinger, E. P., Krause, P. J., Martone, W. J., McGowan, J. E., Sweet, R. L., & Wenzel, R. P. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.3.421 · Cited by 223
Mahenthiralingam, E., Vandamme, P., Campbell, M. E., Henry, D. A., Gravelle, A. M., Wong, L. T. K., Davidson, A. G. F., Wilcox, P. G., Nakielna, B., & Speert, D. P. (2001) · Clinical Infectious Diseases · doi:10.1086/322684 · Cited by 222
Ratjen, F., Döring, G., & Nikolaizik, W. H. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06124-4 · Cited by 218
Self-citationEffects of Viral Lower Respiratory Tract Infection on Lung Function in Infants With Cystic Fibrosis
Hiatt, P. W., Grace, S. C., Kozinetz, C. A., Raboudi, S. H., Treece, D. G., Taber, L. H., & Piedra, P. A. (1999) · Pediatrics · doi:10.1542/peds.103.3.619 · Cited by 215
Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis
Montuschi, P. (2000) · Thorax · doi:10.1136/thorax.55.3.205 · Cited by 214
Vandamme, P. (2002) · FEMS Immunology and Medical Microbiology · doi:10.1016/s0928-8244(02)00301-2 · Cited by 213
Johansen, H. K., & Hoiby, N. (1992) · Thorax · doi:10.1136/thx.47.2.109 · Cited by 205
Self-citationNEBULISED COLOMYCIN FOR EARLY PSEUDOMONAS COLONISATION IN CYSTIC FIBROSIS
Littlewood, J. M., Miller, M. G., Ghoneim, A. T., & Ramsden, C. H. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92222-6 · Cited by 203
Nontuberculous Mycobacteria: II: Nested-Cohort Study of Impact on Cystic Fibrosis Lung Disease
Olivier, K. N., Weber, D. J., Lee, J.-H., Handler, A., Tudor, G., Molina, P. L., Tomashefski, J., & Knowles, M. R. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-679oc · Cited by 201
Wiesemann, H. G., Steinkamp, G., Ratjen, F., Bauernfeind, A., Przyklenk, B., Döring, G., & von der Hardt, H. (1998) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199802)25:2<88::aid-ppul3>3.0.co;2-j · Cited by 200
Self-citationAn epidemic Burkholderia cepacia complex strain identified in soil
LiPuma, J. J., Spilker, T., Coenye, T., & Gonzalez, C. F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08836-0 · Cited by 199
Severe viral respiratory infections in infants with cystic fibrosis
Armstrong, D., Grimwood, K., Carlin, J. B., Carzino, R., Hull, J., Olinsky, A., & Phelan, P. D. (1998) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199812)26:6<371::aid-ppul1>3.0.co;2-n · Cited by 198
Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis
Geller, D. E., Kaplowitz, H., Light, M. J., & Colin, A. A. (1999) · Chest · doi:10.1378/chest.116.3.639 · Cited by 198
Agricultural Use of Burkholderia (Pseudomonas) cepacia: A Threat to Human Health?
Holmes, A., Govan, J., & Goldstein, R. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0402.980209 · Cited by 193
Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis
Warnock, L., & Gates, A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001401.pub3 · Cited by 190
Microbiology of lung infection in cystic fibrosis
Govan, J. R. W., & Nelson, J. W. (1992) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072585 · Cited by 188
PETERSEN, N. T., HØIBY, N., MORDHORST, C. H., LIND, K., FLENSBORG, E. W., & BRUUN, B. (1981) · Acta Paediatrica · doi:10.1111/j.1651-2227.1981.tb05757.x · Cited by 184
West, S. E. H., Zeng, L., Lee, B. L., Kosorok, M. R., Laxova, A., Rock, M. J., Splaingard, M. J., & Farrell, P. M. (2002) · JAMA · doi:10.1001/jama.287.22.2958 · Cited by 182
Cystic fibrosis lung inflammation: early, sustained, and severe.
Cantin, A. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.4.7697269 · Cited by 181
Lai, H.-C., FitzSimmons, S. C., Allen, D. B., Kosorok, M. R., Rosenstein, B. J., Campbell, P. W., & Farrell, P. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421204 · Cited by 179
Primm, T. P., & Falkinham, J. O. (2014) · Reference Module in Biomedical Sciences · doi:10.1016/b978-0-12-801238-3.03009-9 · Cited by 178
Detecting early structural lung damage in cystic fibrosis
Tiddens, H. A. W. M. (2002) · Pediatric Pulmonology · doi:10.1002/ppul.10134 · Cited by 177
Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF
Navarro, J., Rainisio, M., Harms, H. K., Hodson, M. E., Koch, C., Mastella, G., Strandvik, B., & McKenzie, S. G. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00068901 · Cited by 171
Mycobacterium abscessus Infection in Cystic Fibrosis: Colonization or Infection?
CULLEN, A. R., CANNON, C. L., MARK, E. J., & COLIN, A. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.9903062 · Cited by 168
Stutman, H. R., Lieberman, J. M., Nussbaum, E., & Marks, M. I. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.121930 · Cited by 166
Colonization of the Respiratory Tract with Pseudomonas cepacia in Cystic Fibrosis
Tablan, O. C., Martone, W. J., Doershuk, C. F., Stern, R. C., Thomassen, M. J., Klinger, J. D., White, J. W., Carson, L. A., & Jarvis, W. R. (1987) · Chest · doi:10.1378/chest.91.4.527 · Cited by 161
Characterization and Use of a DNA Probe as an Epidemiological Marker for Pseudomonas aeruginosa
Ogle, J. W., Janda, J. M., Woods, D. E., & Vasil, M. L. (1987) · Journal of Infectious Diseases · doi:10.1093/infdis/155.1.119 · Cited by 160
Chatfield, S., Owen, G., Ryley, H. C., Williams, J., Alfaham, M., Goodchild, M. C., & Weller, P. (1991) · Archives of Disease in Childhood · doi:10.1136/adc.66.1_spec_no.29 · Cited by 158
Physical training for cystic fibrosis
Bradley, J. M., & Moran, F. M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002768.pub2 · Cited by 157
Clinical outcomes of newborn screening for cystic fibrosis
Waters, D., Wilcken, B. M., Irwig, L., Asperen, P. V., Mellis, C., Simpson, J. M., Brown, J., & Gaskin, K. J. (1999) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.80.1.f1 · Cited by 156
An atypical Pseudomonas aeruginosa associated with cystic fibrosis of the pancreas
Doggett, R. G., Harrison, G. M., Stillwell, R. N., & Wallis, E. S. (1966) · The Journal of Pediatrics · doi:10.1016/s0022-3476(66)80152-x · Cited by 152
Suri, R., Metcalfe, C., Lees, B., Grieve, R., Flather, M. D., Normand, C. E. M., Thompson, S. G., Bush, A., & Wallis, C. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06412-1 · Cited by 152
Burkholderia cepacia Genomovar III Is a Common Plant-Associated Bacterium
Balandreau, J., Viallard, V., Cournoyer, B., Coenye, T., Laevens, S., & Vandamme, P. A. R. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.2.982-985.2001 · Cited by 150
Dankert-Roelse, J. E., & Meerman, G. J. T. (1995) · Thorax · doi:10.1136/thx.50.7.712 · Cited by 142
Pseudomonas aeruginosa as an Opportunistic Pathogen
Campa, M., Bendinelli, M., & Friedman, H. (1993) · Infectious agents and pathogenesis · doi:10.1007/978-1-4615-3036-7 · Cited by 141
Pulmonary oxidative stress response in young children with cystic fibrosis
Hull, J., Vervaart, P., Grimwood, K., & Phelan, P. D. (1997) · Thorax · doi:10.1136/thx.52.6.557 · Cited by 139
Skov, M., Main, K. M., Ib, S., Müller, J., Koch, C., & Lanng, S. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00248002 · Cited by 136
Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis
Nepomuceno, I. B., Esrig, S., & Moss, R. B. (1999) · CHEST Journal · doi:10.1378/chest.115.2.364 · Cited by 135
Hentges, D. J., Stein, A. J., Casey, S. W., & Que, J. U. (1985) · Infection and Immunity · doi:10.1128/iai.47.1.118-122.1985 · Cited by 134
Immediate and long-term effects of chest physiotherapy in patients with cystic fibrosis
Desmond, K. J., Schwenk, W. F., Thomas, E., Beaudry, P. H., & Coates, A. L. (1983) · The Journal of Pediatrics · doi:10.1016/s0022-3476(83)80579-4 · Cited by 134
An Epidemic ofBurkholderia cepaciaTransmitted between Patients with and without Cystic Fibrosis
Holmes, A. H., Nolan, R. L., Taylor, R., Finley, R. W., Riley, M. A., Jiang, R., Steinbach, S., & Goldstein, R. (1999) · The Journal of Infectious Diseases · doi:10.1086/314699 · Cited by 133
Detecting Stenotrophomonas maltophilia Does Not Reduce Survival of Patients with Cystic Fibrosis
Goss, C. H., Otto, K., Aitken, M. L., & Rubenfeld, G. D. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2109078 · Cited by 131
Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis
Döring, G., & Høiby, N. (1983) · Infection and Immunity · doi:10.1128/iai.42.1.197-201.1983 · Cited by 131
Self-citationRatjen, F. A., Comes, G., Paul, K. P., Posselt, H., Wagner, T. O. F., Harms, K., & for the German Board of the European Registry for Cystic Fibrosis (ERCF) (2001) · Pediatric Pulmonology · doi:10.1002/1099-0496(200101)31:1<13::aid-ppul1001>3.0.co;2-n · Cited by 129
Shawar, R. M., MacLeod, D. L., Garber, R. L., Burns, J. L., Stapp, J. R., Clausen, C. R., & Tanaka, S. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2877 · Cited by 129
Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period.
Weaver, L. T., Green, M. R., Nicholson, K., Mills, J. L., Heeley, M. E., Kuzemko, J. A., Austin, S., Gregory, G. A., Dux, A., & Davis, J. (1994) · Archives of Disease in Childhood · doi:10.1136/adc.70.2.84 · Cited by 127
Distribution and transmission ofPseudomonas aeruginosa andBurkholderia cepacia in a hospital ward
Döring, G., Jansen, S., Noll, H., Grupp, H., Frank, F., Botzenhart, K., Magdorf, K., & Wahn, U. (1996) · Pediatric Pulmonology · Cited by 127
Self-citationRisks of Alternate-Day Prednisone in Patients With Cystic Fibrosis
Rosenstein, B. J., & Eigen, H. (1991) · PEDIATRICS · doi:10.1542/peds.87.2.245 · Cited by 125
Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis
Chen, J. S., Witzmann, K. A., Spilker, T., Fink, R. J., & LiPuma, J. J. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.118430 · Cited by 124
The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro
Stern, M., Caplen, N. J., Browning, J. A., Uta Griesenbach, D., Sorgi, F., Huang, L., Gruenert, D. C., Marriot, C., Crystal, R., Geddes, D. M., et al. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300556 · Cited by 122
Mycobacterial lung disease in cystic fibrosis: a prospective study
Fauroux, B., Delaisi, B., Clément, A., Saizou, C., Moissenet, D., Truffot-Pernot, C., Tournier, G., & Vu-Thien, H. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199704000-00004 · Cited by 122
Postural drainage and gastro-oesophageal reflux in infants with cystic fibrosis
Button, B., Heine, R. G., Catto‐Smith, A. G., et al. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.76.2.148 · Cited by 120
Macromolecular mechanisms of sputum inhibition of tobramycin activity
Hunt, B. E., Weber, A., Berger, A., Ramsey, B. W., & Smith, A. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.34 · Cited by 120
Mérelle, M. E., Schouten, J. P., Gerritsen, J., & Dankert-Roelse, J. E. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00080101 · Cited by 119
Achieving 100% Typeability of Pseudomonas aeruginosa by Pulsed-Field Gel Electrophoresis
Römling, U., & Tümmler, B. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.1.464-465.2000 · Cited by 117
Nontuberculous Mycobacteria in Cystic Fibrosis. An Autopsy Study
Tomashefski, J. F., Stern, R. C., Demko, C. A., & Doershuk, C. F. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.2.8756832 · Cited by 117
McElvaney, N. G., Doujaiji, B., Moan, M. J., Burnham, M. R., Wu, M. C., & Crystal, R. G. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.4_pt_1.1056 · Cited by 116
Screening for cystic fibrosis.
Murray, Cuckle, Taylor, Littlewood, & Hewison (1999) · Health Technology Assessment · doi:10.3310/hta3080 · Cited by 113
van Haren, E. H. J., Lammers, J. J., Festen, J., Heijerman, H. G. M., Groot, C. A. R., & van Herwaarden, C. L. A. (1995) · Respiratory Medicine · doi:10.1016/0954-6111(95)90249-x · Cited by 112
Scotet, V., Braekeleer, M. D., Roussey, M., Rault, G., Parent, P., Dagorne, M., Journel, H., Lemoigne, A., Codet, J.-P., Catheline, M., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02652-0 · Cited by 110
Misidentification of Burkholderia cepacia in US Cystic Fibrosis Treatment Centers
McMenamin, J. D., Zaccone, T. M., Coenye, T., Vandamme, P. A. R., & LiPuma, J. J. (2000) · CHEST Journal · doi:10.1378/chest.117.6.1661 · Cited by 110
The Effect of Respiratory Viral Infections on Patients With Cystic Fibrosis
Ramsey, B. W. (1989) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1989.02150180040017 · Cited by 107
Jones, A. M., Govan, J. R. W., Doherty, C. J., Dodd, M. E., Isalska, B. J., Stanbridge, T. N., & Webb, A. K. (2003) · Thorax · doi:10.1136/thorax.58.6.525 · Cited by 107
Bargon, J., Dauletbaev, N., Köhler, B., Wolf, M., Posselt, H., & Wagner, T. O. F. (1999) · Respiratory Medicine · doi:10.1016/s0954-6111(99)90270-6 · Cited by 102
REDUCED MORBIDITY IN PATIENTS WITH CYSTIC FIBROSIS DETECTED BY NEONATAL SCREENING
Wilcken, B. M., & Chalmers, G. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92623-6 · Cited by 101
di Sant'Agnese, P. E. A. (1946) · American journal of diseases of children · doi:10.1001/archpedi.1946.02020300024003 · Cited by 99
Sajjan, U. S., Tran, L. T., Solé, N. A., Rovaldi, C., Akiyama, A., Friden, P. M., Forstner, J., & Rothstein, D. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3437-3444.2001 · Cited by 98
Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis
Balfour-Lynn, I. M., Klein, N. J., & Dinwiddie, R. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.2.124 · Cited by 98
Bardouniotis, E., Ceri, H., & Olson, M. E. (2002) · Current Microbiology · doi:10.1007/s00284-002-3796-4 · Cited by 96
Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis
van der Schans, C. P., Prasad, A., & Main, E. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001401 · Cited by 94
Tumour Necrosis Factor-α, Resting Energy Expenditure and Cachexia in Cystic Fibrosis
Elborn, J. S., Cordon, S. M., Western, P., Macdonald, I. A., & Shale, D. J. (1993) · Clinical Science · doi:10.1042/cs0850563 · Cited by 93
Siret, D., Bretaudeau, G., Branger, B., Dabadie, A., Dagorne, M., David, V., Braekeleer, M. D., Moisan‐Petit, V., Picherot, G., Rault, G., et al. (2003) · Pediatric Pulmonology · doi:10.1002/ppul.10259 · Cited by 93
Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis.
Kc, M., & Zimmerman, J. J. (1993) · PubMed · Cited by 93
Nontuberculous Mycobacteria in Patients with Cystic Fibrosis
Oliver, A., Maiz, L., Cantón, R., Escobar, H., Baquero, F., & Gómez-Mampaso, E. (2001) · Clinical Infectious Diseases · doi:10.1086/319987 · Cited by 86
Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections
Pribble, C. G., Black, P., Bosso, J. A., & Turner, R. B. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80530-x · Cited by 84
Haemophilus Influenzae in Lung Explants of Patients with End-stage Pulmonary Disease
Möller, L. V. M., Timens, W., van der Bij, W., Kooi, K., de Wever, B., Dankert, J., & van Alphen, L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.9707010 · Cited by 83
Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screening
Dankert-Roelse, J. E., Meerman, G. J. T., Martijn, A., ten Kate, L. P., & Knol, K. (1989) · The Journal of Pediatrics · doi:10.1016/s0022-3476(89)80552-9 · Cited by 82
Early Versus Late Diagnosis: Psychological Impact on Parents of Children With Cystic Fibrosis
Mérelle, M. E., Huisman, J., der Vecht, A. A.-V., Taat, F., Bezemer, D., Griffioen, R. W., Brinkhorst, G., & Dankert-Roelse, J. E. (2003) · PEDIATRICS · doi:10.1542/peds.111.2.346 · Cited by 80
Antiseptic Technology: Access, Affordability, and Acceptance
Boyce, J. M. (2001) · Emerging infectious diseases · doi:10.3201/eid0702.010216 · Cited by 78
Birke, F. W., Meade, C. J., Anderskewitz, R., Speck, G., & Jennewein, H. M. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29557-4 · Cited by 78
Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis
Worlitzsch, D., Herberth, G., Ulrich, M., & Döring, G. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11020377 · Cited by 76
Self-citationCost of care and clinical condition in paediatric cystic fibrosis patients
Baumann, U., Stocklossa, C., Greiner, W., von der Schulenburg, J. G., & von der Hardt, H. (2003) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(03)00024-9 · Cited by 75
Johansen, H. K., Hougen, H. P., Rygaard, J., & Høiby, N. (1996) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-618.x · Cited by 74
Branger, C., Gardye, C., & Lambert-Zechovsky, N. (1996) · Journal of Medical Microbiology · doi:10.1099/00222615-45-4-294 · Cited by 73
Suri, R., Marshall, L. J., Wallis, C., Metcalfe, C., Bush, A., & Shute, J. K. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2110015 · Cited by 71
Bange, F., Brown, B. A., Smaczny, C., Wallace, R. J., & Böttger, E. C. (2001) · Clinical Infectious Diseases · doi:10.1086/320525 · Cited by 71
Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis
Bosworth, D. G., & Nielson, D. W. (1997) · Pediatric Pulmonology · Cited by 69
Sputum induction in young cystic fibrosis patients
Boeck, K. D., Alifier, M., & Vandeputte, S. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.16a16.x · Cited by 67
Microbiology of cystic fibrosis lung infections: themes and issues.
Govan, J. R. W., & Nelson, J. W. (1993) · PubMed · Cited by 66
Breath isoprene during acute respiratory exacerbation in cystic fibrosis
McGrath, L. T., Patrick, R., Mallon, P. W. G., et al. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.16f08.x · Cited by 66
Antibiotic treatment of cystic fibrosis
Marino, J. T. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80748-2 · Cited by 66
Home nebulizer use among patients with cystic fibrosis
Rosenfeld, M., Emerson, J., Astley, S. J., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70497-4 · Cited by 66
Nikolaizik, W. H., Moser, M., Crameri, R., Little, S. A., Warner, J. O., Blaser, K., & Schöni, M. H. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.2.7633719 · Cited by 65
ANTIBIOTIC TREATMENT OF STAPHYLOCOCCUS AUREUS INFECTION IN CYSTIC FIBROSIS
Szaff, M., & Høiby, N. (1982) · Acta Paediatrica · doi:10.1111/j.1651-2227.1982.tb09526.x · Cited by 64
Cystic fibrosis‐related deaths in infancy and the effect of newborn screening
Doull, I. J. M., Ryley, H. C., Weller, P. H., et al. (2001) · Pediatric Pulmonology · doi:10.1002/ppul.1059 · Cited by 64
The Role of Mycobacteria Other Than Tuberculosis (MOTT) in Patients with Cystic Fibrosis
Hjelt, K., Højlyng, N., Howitz, P., Illum, N. O., Munk, E., Valerius, N. H., Fuursted, K., Hansen, K. N., Heltberg, I., & Koch, C. (1994) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549409011815 · Cited by 61
Karpati, F., Malmborg, A. S., Alfredsson, H., Hjelte, L., & Strandvik, B. (1994) · Infection · doi:10.1007/bf01739911 · Cited by 60
Jensen, E., Giwercman, B., Ojeniyi, B., Bangsborg, J., Hansen, A., Koch, C., Fiehn, N., & Høiby, N. (1997) · Journal of Hospital Infection · doi:10.1016/s0195-6701(97)90117-1 · Cited by 60
Physical training for cystic fibrosis
Bradley, J. M., & Moran, F. M. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002768 · Cited by 57
Conventional chest physiotherapy compared to other forms of chest physiotherapy for cystic fibrosis
Main, E., Prasad, A., & van der Schans, C. (2003) · doi:10.1002/14651858.cd002011 · Cited by 56
Ecology and Epidemiology of Pseudomonas aeruginosa
Botzenhart, K., & Döring, G. (1993) · Infectious Agents and Pathogenesis · doi:10.1007/978-1-4615-3036-7_1 · Cited by 53
Self-citationThe impact of early cystic fibrosis diagnosis on pulmonary function in children
Wang, S., O’Leary, L. A., FitzSimmons, S. C., & Khoury, M. J. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.129845 · Cited by 53
Phillips, G., Pike, S., Rosenthal, M. A., et al. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12040954 · Cited by 51
Molecular epidemiology of airway colonisation by Aspergillus fumigatus in cystic fibrosis patients
Cimon, B., Symoens, F., Zouhair, R., Chabasse, D., NOLARD, N., Defontaine, A., & Bouchara, J. (2001) · Journal of Medical Microbiology · doi:10.1099/0022-1317-50-4-367 · Cited by 50
Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
Skov, M., Høiby, N., & Koch, C. (2002) · Allergy · doi:10.1034/j.1398-9995.2002.23583.x · Cited by 49
Lévy, J. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80755-7 · Cited by 47
Hoogkamp-Korstanje, J. A. A., Meis, J. F. G. M., Kissing, J., van der Laag, J., & Melchers, W. J. G. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.3.572-575.1995 · Cited by 43
Cantin, A. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9608033 · Cited by 41
Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient
Main, K. M., Skov, M., Ib, S., Dige‐Petersen, H., Müller, J., Koch, C., & Lanng, S. (2002) · Acta Paediatrica · doi:10.1111/j.1651-2227.2002.tb02894.x · Cited by 40
Three cases of pulmonary aspergilloma in adult patients with cystic fibrosis.
Maguire, C., Hayes, J. P., Hayes, M., Masterson, J., & FitzGerald, M. X. (1995) · Thorax · doi:10.1136/thx.50.7.805 · Cited by 40
The German cystic fibrosis quality assurance project: clinical features in children and adults
Wiedemann, B., Steinkamp, G., Sens, B., & Stern, M. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00053901 · Cited by 39
Gabbay, E., Fisher, A., Small, T., Leonard, A., & Corris, P. A. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11020467 · Cited by 38
Cuckle, H., & Murray, J. (1998) · Disease Management & Health Outcomes · doi:10.2165/00115677-199803040-00001 · Cited by 35
On the Transport of Lipoplexes Through Cystic Fibrosis Sputum
Sanders, N. N., Rompaey, E. V., Smedt, S. C. D., & Demeester, J. (2002) · Pharmaceutical Research · doi:10.1023/a:1015139527747 · Cited by 34
Potential benefits of the UK Cystic Fibrosis Database.
Mehta, G., Sims, E. J., Culross, F., Jd, M., & Mehta, A. (2004) · Europe PMC (PubMed Central) · Cited by 33
Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis.
Costello, C. M., O'CONNOR, C. M., Finlay, G. A., Shiels, P., FitzGerald, M. X., & Hayes, J. P. (1996) · Thorax · doi:10.1136/thx.51.6.619 · Cited by 32
Newborn screening for cystic fibrosis: A paradigm for public health genetics policy development
Farrell, P. M., Kosorok, M. R., Rock, M. J., Laxova, A., Zeng, L., Hoffman, G. L., Laessig, R. H., Splaingard, M., & Wisconsin Cystic Fibrosis Neonatal Screening Study Group (2000) · doi:10.1093/acprof:oso/9780195128307.003.0021 · Cited by 30
Screening for Cystic Fibrosis — Time to Change Our Position?
Dankert-Roelse, J. E., & Meerman, G. J. T. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371409 · Cited by 28
Early pulmonary disease in cystic fibrosis
Accurso, F. J. (1997) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-199711000-00002 · Cited by 28
Cross-contamination potential of saliva ejectors used in dentistry
Barbeau, J. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90308-5 · Cited by 26
Cited by
Antibiotic resistance of bacterial biofilms
Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S., & Ciofu, O. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.011 · Cited by 3,225
Nährlich, L., Mainz, J. G., Adams, C., Engel, C., Herrmann, G., Icheva, V., Lauer, J., Deppisch, C., Wirth, A., Unger, K., et al. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350071 · Cited by 2,525
Self-citationThe clinical impact of bacterial biofilms
Høiby, N., Ciofu, O., Johansen, H. K., Song, Z., Moser, C., Jensen, P. Ø., Molin, S., Givskov, M., Tolker‐Nielsen, T., & Bjarnsholt, T. (2011) · International Journal of Oral Science · doi:10.4248/ijos11026 · Cited by 894
ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014
Høiby, N., Bjarnsholt, T., Moser, C., Bassi, G. L., Coenye, T., Donelli, G., Hall-Stoodley, L., Holá, V., Imbert, C., Kirketerp-Møller, K., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.10.024 · Cited by 726
Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective
Folkesson, A., Jelsbak, L., Yang, L., Johansen, H. K., Ciofu, O., Høiby, N., & Molin, S. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2907 · Cited by 715
Metadata
- Authors
- Döring, G., & Hoiby, N.
- Venue
- Journal of Cystic Fibrosis
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 3
- Issue
- 2
- Pages
- 67-91
- ISSN
- 1569-1993 (ISSN-L)
- OpenAlex
- W2164471608
- Cited by
- 304
- References
- 205
- FWCI
- 9.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.